Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 134

    1.

    Microvascular complications of impaired glucose tolerance.

    Singleton JR, Smith AG, Russell JW, Feldman EL.

    Diabetes. 2003 Dec;52(12):2867-73. Review.PMID: 14633845 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Mechanisms of disease: Pathway-selective insulin resistance and microvascular complications of diabetes.

    Groop PH, Forsblom C, Thomas MC.

    Nat Clin Pract Endocrinol Metab. 2005 Dec;1(2):100-10. Review.PMID: 16929378 [PubMed - indexed for MEDLINE]Related articles

    3.

    Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management.

    Petersen JL, McGuire DK.

    Diab Vasc Dis Res. 2005 Feb;2(1):9-15. Review.PMID: 16305067 [PubMed - indexed for MEDLINE]Related articles

    4.

    [Early diagnosis of peripheral neuropathy in patients with impaired glucose tolerance (IGT)]

    Yagihashi S.

    Nippon Rinsho. 2005 Jun;63 Suppl 6:640-6. Review. Japanese. No abstract available. PMID: 15999784 [PubMed - indexed for MEDLINE]Related articles

    5.

    Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.

    Henkel E, Menschikowski M, Koehler C, Leonhardt W, Hanefeld M.

    Metabolism. 2005 Sep;54(9):1168-73.PMID: 16125528 [PubMed - indexed for MEDLINE]Related articles

    6.

    [The influence of physical training on metabolic indices in men with myocardial infarction and impaired glucose tolerance]

    Stochmal A, Jasiak-Tyrkalska B, Stochmal E, Huszno B, Kawecka-Jaszcz K.

    Przegl Lek. 2007;64(6):410-5. Polish. PMID: 18159849 [PubMed - indexed for MEDLINE]Related articles

    7.

    Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies.

    Pacher P, Obrosova IG, Mabley JG, Szabó C.

    Curr Med Chem. 2005;12(3):267-75. Review.PMID: 15723618 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome.

    Abdul-Ghani M, Nawaf G, Nawaf F, Itzhak B, Minuchin O, Vardi P.

    Isr Med Assoc J. 2006 Jun;8(6):378-82.PMID: 16833164 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Impaired glucose tolerance: is there a case for pharmacologic intervention?

    Costa A, Conget I, Gomis R.

    Treat Endocrinol. 2002;1(4):205-10. Review.PMID: 15799213 [PubMed - indexed for MEDLINE]Related articles

    10.

    Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus.

    Guerrero-Romero F, Rodríguez-Morán M.

    Eur J Clin Invest. 2006 Nov;36(11):796-802.PMID: 17032347 [PubMed - indexed for MEDLINE]Related articles

    11.

    Monosaccharides in health and disease.

    Levine R.

    Annu Rev Nutr. 1986;6:211-24. Review.PMID: 3524617 [PubMed - indexed for MEDLINE]Related articles

    12.

    Impaired glucose tolerance, impaired fasting glycaemia and cardiovascular risk.

    Sanusi H.

    Acta Med Indones. 2004 Jan-Mar;36(1):36-41. Review.PMID: 15673935 [PubMed - indexed for MEDLINE]Related articles

    13.

    Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose.

    Festa A, D'Agostino R Jr, Hanley AJ, Karter AJ, Saad MF, Haffner SM.

    Diabetes. 2004 Jun;53(6):1549-55.PMID: 15161760 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Diabetic retinopathy, nephropathy, and neuropathy with normal glucose tolerance.

    Kabadi UM.

    Diabetes Care. 1986 Mar-Apr;9(2):211-2. No abstract available. PMID: 3698786 [PubMed - indexed for MEDLINE]Related articles

    15.

    Vascular disease in the metabolic syndrome: do we need to target the microcirculation to treat large vessel disease?

    Krentz AJ, Clough G, Byrne CD.

    J Vasc Res. 2009;46(6):515-26. Epub 2009 Jun 30. Review.PMID: 19571572 [PubMed - indexed for MEDLINE]Related articles

    16.

    Screening for type 2 diabetes: literature review and economic modelling.

    Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E, Williams R, John A.

    Health Technol Assess. 2007 May;11(17):iii-iv, ix-xi, 1-125. Review.PMID: 17462167 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Relation of metabolic control to complications in diabetes mellitus.

    Leslie ND, Sperling MA.

    J Pediatr. 1986 Apr;108(4):491-7. No abstract available. PMID: 3514827 [PubMed - indexed for MEDLINE]Related articles

    18.

    Adipocytes in subjects with impaired fasting glucose and impaired glucose tolerance are resistant to the anti-lipolytic effect of insulin.

    Abdul-Ghani MA, Molina-Carrion M, Jani R, Jenkinson C, Defronzo RA.

    Acta Diabetol. 2008 Sep;45(3):147-50. Epub 2008 Mar 21.PMID: 18357404 [PubMed - indexed for MEDLINE]Related articles

    19.

    Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus.

    Prior JO, Quiñones MJ, Hernandez-Pampaloni M, Facta AD, Schindler TH, Sayre JW, Hsueh WA, Schelbert HR.

    Circulation. 2005 May 10;111(18):2291-8. Epub 2005 Apr 25.PMID: 15851590 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.

    Yamagishi S, Nakamura K, Takeuchi M.

    Med Hypotheses. 2005;65(1):152-4. Epub 2005 Jan 28.PMID: 15893133 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data